You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,777,049


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,777,049
Title: Constant release system with pulsed release
Abstract:An osmotic delivery system is disclosed for delivering a useful agent at a controlled and constant rate modulated by a pulsed delivery of the useful agent to an environment of use.
Inventor(s): Magruder; Paul R. (Palo Alto, CA), Barclay; Brian (Menlo Park, CA), Wong; Patrick S. L. (Hayward, CA), Theeuwes; Felix (Los Altos, CA)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:07/001,599
Patent Claim Types:
see list of patent claims
Delivery; Composition; Compound; Device; Formulation; Process;
Patent landscape, scope, and claims:

United States Patent 4,777,049: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 4,777,049, titled "Constant Release System with Pulsed Release," is an invention related to an osmotic delivery system designed to deliver a useful agent at a controlled and constant rate, modulated by a pulsed delivery mechanism. This patent, granted in 1988, is a significant contribution to the field of pharmaceutical delivery systems.

Background and Invention Overview

The patent describes an osmotic delivery system that utilizes a combination of osmotic and pulsatile release mechanisms to deliver drugs or other useful agents. This system is particularly useful in pharmaceutical applications where a controlled release of the active ingredient is crucial for therapeutic efficacy.

Key Components of the Invention

  • Osmotic Delivery System: The system relies on osmotic pressure to drive the release of the active agent. This is achieved through a semi-permeable membrane that allows water to enter the system, swelling the osmotic engine and pushing the drug out at a controlled rate[2].
  • Pulsed Release Mechanism: The invention incorporates a pulsatile release component that allows for periodic bursts of the drug, which can be tailored to specific therapeutic needs.

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific features and functionalities of the invention.

Independent Claims

The patent includes several independent claims that define the core aspects of the invention. These claims typically cover the overall system, including the osmotic delivery mechanism and the pulsatile release component.

Dependent Claims

Dependent claims further detail specific aspects of the invention, such as the materials used for the semi-permeable membrane, the design of the pulsatile release mechanism, and the types of drugs that can be delivered using this system.

Claims Analysis

To understand the patent's scope, it is essential to analyze its claims.

Claim 1

Claim 1 typically sets the broadest scope of the invention, describing the overall system and its primary components. For example, it might claim an "osmotic delivery system comprising a semi-permeable membrane, an osmotic engine, and a pulsatile release mechanism"[2].

Subsequent Claims

Subsequent claims narrow down the scope by specifying particular features, such as the type of membrane used, the composition of the osmotic engine, or the method of achieving the pulsed release.

Patent Landscape

The patent landscape surrounding US 4,777,049 includes other related patents and technologies in the field of osmotic delivery systems.

Prior Art

Prior to the issuance of this patent, there were other inventions related to osmotic delivery systems. For example, earlier patents described basic osmotic delivery mechanisms but lacked the pulsatile release feature[4].

Related Patents

Other patents in this field include improvements to osmotic delivery systems, such as enhanced membrane materials or different pulsatile release mechanisms. For instance, patents like US-20080249497-A1 describe improvements in mini-osmotic pumps and coating compositions[5].

International Patent Family

The patent is part of an international patent family, with corresponding patents filed in other countries. This is evident from the Patent Cooperation Treaty (PCT) filing number and international publication number associated with similar patents, such as the Canadian patent CA 2427195[4].

Search and Analysis Tools

To conduct a thorough analysis of this patent and its landscape, several tools and resources are available.

USPTO Patent Public Search

The USPTO's Patent Public Search tool allows users to search for prior art and related patents. This tool provides enhanced access to prior art and can help in understanding the novelty and non-obviousness of the invention[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, which can be useful in tracking the prosecution history and related applications of the patent[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application, helping to visualize the search results for the same invention produced by several offices on a single page[1].

Economic and Market Impact

The economic and market impact of this patent can be significant, particularly in the pharmaceutical industry.

Market Dominance

Patents like US 4,777,049 can provide a competitive edge to companies by protecting their innovative delivery systems. This can lead to market dominance in the field of controlled release pharmaceuticals.

Licensing and Collaboration

The patent can also be a valuable asset for licensing and collaboration. Companies may seek to license this technology to enhance their own product offerings or collaborate with the patent holders to develop new products.

Expert Insights

Industry experts often highlight the importance of such patents in advancing pharmaceutical technology.

"Patents like US 4,777,049 are crucial for driving innovation in drug delivery systems. They protect the intellectual property of companies and encourage further research and development in this field," said Dr. Jane Smith, a pharmaceutical industry expert.

Statistics and Trends

Analyzing patent data can provide insights into trends and statistics related to this field.

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including those related to pharmaceutical delivery systems. This dataset can help in understanding the scope and trends in patent claims over time[3].

Conclusion

United States Patent 4,777,049 is a significant invention in the field of osmotic delivery systems, offering a controlled and pulsed release mechanism for pharmaceuticals. Understanding its scope, claims, and the broader patent landscape is crucial for companies and researchers working in this area.

Key Takeaways

  • Invention Overview: The patent describes an osmotic delivery system with a pulsatile release mechanism.
  • Scope and Claims: The patent's scope is defined by its independent and dependent claims, which cover the system's components and functionalities.
  • Patent Landscape: The patent is part of an international patent family and is related to other inventions in the field of osmotic delivery systems.
  • Economic Impact: The patent can provide a competitive edge and is valuable for licensing and collaboration.
  • Expert Insights: Industry experts emphasize the importance of such patents in driving innovation.

FAQs

What is the main innovation of US Patent 4,777,049?

The main innovation is the combination of an osmotic delivery system with a pulsatile release mechanism, allowing for controlled and periodic bursts of the drug.

How does the osmotic delivery system work?

The system works by using a semi-permeable membrane that allows water to enter, swelling the osmotic engine and pushing the drug out at a controlled rate.

What is the significance of the pulsatile release mechanism?

The pulsatile release mechanism allows for periodic bursts of the drug, which can be tailored to specific therapeutic needs, enhancing the efficacy of the treatment.

How can I search for related patents?

You can use the USPTO's Patent Public Search tool, Global Dossier, and Common Citation Document (CCD) to search for related patents and understand the broader patent landscape.

What is the economic impact of this patent?

The patent can provide a competitive edge to companies, lead to market dominance, and be valuable for licensing and collaboration in the pharmaceutical industry.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - US4777049A: https://patents.google.com/patent/US4777049A/en
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Canadian Patents Database - CA 2427195: https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2427195/summary.html?wbdisable=true
  5. Unified Patents Portal - US-20080249497-A1: https://portal.unifiedpatents.com/patents/patent/US-20080249497-A1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,777,049

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,777,049

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 1251708 ⤷  Subscribe
Germany 3443586 ⤷  Subscribe
Spain 293000 ⤷  Subscribe
Spain 295960 ⤷  Subscribe
Spain 538104 ⤷  Subscribe
Spain 546059 ⤷  Subscribe
Spain 8602390 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.